Add to ORKGTreatment with chronic corticosteroids has been associated with frequent significant adverse effects. We hypothesized that the major side effect profile of a long-term, low-dose prednisone regimen for OMG was low
Myasthenia Gravis is an autoimmune disorder characterized by a reduction of available postsynaptic a...
We reviewed retrospectively 114 prednisone dose reduction attempts in 63 myasthenic patients. Dose r...
SUMMARY An 8 year old girl with ocular myasthenia gravis was treated with high dose intravenous immu...
Ocular myasthenia gravis is a chronic disease generally requiring years of treatment. Treatment cons...
The majority of patients with myasthenia gravis (MG) initially present with ocular symptoms. An unre...
We studied the long-term outcome of prednisone therapy in 104 patients with myasthenia gravis (MG). ...
Ocular myasthenia gravis (OMG) may produce debilitating diplopia or ptosis leading to significant vi...
Currently, adrenal corticosteroids (steroids) are used for a wide variety of clinical conditions. St...
Corticosteroids form the cornerstone of treatment for noninfectious uveitis, but their safety profil...
Chronic, high-dose, oral prednisone has been the mainstay of myasthenia gravis treatment for decades...
Corticosteroids are known to cause many ocular and systemic side effects when administered by oral o...
Glucocorticoids are often required for adequate control of inflammation in many serious inflammatory...
Background: Autoimmune hepatitis requires long-term therapy, and systemic corticosteroids are the ba...
Corticosteroid therapy is of great value in many types of eye disease. The indications are briefly d...
Background: High dose oral prednisolone (100 mg/day) in Graves′ orbitopathy (GO) is limited by lesse...
Myasthenia Gravis is an autoimmune disorder characterized by a reduction of available postsynaptic a...
We reviewed retrospectively 114 prednisone dose reduction attempts in 63 myasthenic patients. Dose r...
SUMMARY An 8 year old girl with ocular myasthenia gravis was treated with high dose intravenous immu...
Ocular myasthenia gravis is a chronic disease generally requiring years of treatment. Treatment cons...
The majority of patients with myasthenia gravis (MG) initially present with ocular symptoms. An unre...
We studied the long-term outcome of prednisone therapy in 104 patients with myasthenia gravis (MG). ...
Ocular myasthenia gravis (OMG) may produce debilitating diplopia or ptosis leading to significant vi...
Currently, adrenal corticosteroids (steroids) are used for a wide variety of clinical conditions. St...
Corticosteroids form the cornerstone of treatment for noninfectious uveitis, but their safety profil...
Chronic, high-dose, oral prednisone has been the mainstay of myasthenia gravis treatment for decades...
Corticosteroids are known to cause many ocular and systemic side effects when administered by oral o...
Glucocorticoids are often required for adequate control of inflammation in many serious inflammatory...
Background: Autoimmune hepatitis requires long-term therapy, and systemic corticosteroids are the ba...
Corticosteroid therapy is of great value in many types of eye disease. The indications are briefly d...
Background: High dose oral prednisolone (100 mg/day) in Graves′ orbitopathy (GO) is limited by lesse...
Myasthenia Gravis is an autoimmune disorder characterized by a reduction of available postsynaptic a...
We reviewed retrospectively 114 prednisone dose reduction attempts in 63 myasthenic patients. Dose r...
SUMMARY An 8 year old girl with ocular myasthenia gravis was treated with high dose intravenous immu...